Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Additional paid-in capital
Accumulated deficit
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2019   116,581,683,000      
Beginning balance at Dec. 31, 2019 $ (56,254) $ 12 $ 427,579 $ (478,035) $ (5,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Consideration issued for business combination (in shares)   52,794,775,000      
Consideration issued for business combination 432,144 $ 5 432,139    
Equity-based compensation 584   435   149
Change in non-controlling interests allocation 0   (33,600)   33,600
Net income (loss) (44,474)     (41,018) (3,456)
Ending balance at Mar. 31, 2020 332,000 $ 17 826,553 (519,053) 24,483
Ending balance (in shares) at Mar. 31, 2020   169,376,458,000      
Beginning balance (in shares) at Dec. 31, 2019   116,581,683,000      
Beginning balance at Dec. 31, 2019 (56,254) $ 12 427,579 (478,035) (5,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (51,292)        
Ending balance at Sep. 30, 2020 327,123 $ 17 826,355 (525,382) 26,133
Ending balance (in shares) at Sep. 30, 2020   169,376,458,000      
Beginning balance (in shares) at Mar. 31, 2020   169,376,458,000      
Beginning balance at Mar. 31, 2020 332,000 $ 17 826,553 (519,053) 24,483
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 772   434   338
Change in non-controlling interests allocation 0   (1,406)   1,406
Net income (loss) (27,365)     (25,238) (2,127)
Ending balance at Jun. 30, 2020 305,407 $ 17 825,581 (544,291) 24,100
Ending balance (in shares) at Jun. 30, 2020   169,376,458,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 1,168   863   305
Change in non-controlling interests allocation 0   (89)   89
Net income (loss) 20,548     18,909 1,639
Ending balance at Sep. 30, 2020 $ 327,123 $ 17 826,355 (525,382) 26,133
Ending balance (in shares) at Sep. 30, 2020   169,376,458,000      
Beginning balance (in shares) at Dec. 31, 2020 169,717,416 169,717,146,000      
Beginning balance at Dec. 31, 2020 $ 293,827 $ 17 831,226 (563,441) 26,025
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Consideration issued for business combination (in shares)   3,968,900,000      
Consideration issued for business combination 30,172 $ 1 30,171    
Equity-based compensation 1,414   1,160   254
Change in non-controlling interests allocation 0   (2,620)   2,620
Net income (loss) (32,213)     (29,409) (2,804)
Ending balance at Mar. 31, 2021 $ 293,200 $ 18 859,937 (592,850) 26,095
Ending balance (in shares) at Mar. 31, 2021   173,686,046,000      
Beginning balance (in shares) at Dec. 31, 2020 169,717,416 169,717,146,000      
Beginning balance at Dec. 31, 2020 $ 293,827 $ 17 831,226 (563,441) 26,025
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercised (in shares) 230,000        
Net income (loss) $ (120,622)        
Ending balance at Sep. 30, 2021 $ 793,056 $ 25 1,460,053 (677,491) 10,469
Ending balance (in shares) at Sep. 30, 2021 245,583,108 245,583,108,000      
Beginning balance (in shares) at Mar. 31, 2021   173,686,046,000      
Beginning balance at Mar. 31, 2021 $ 293,200 $ 18 859,937 (592,850) 26,095
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 1,348   1,117   231
Change in non-controlling interests allocation 0   (3,106)   3,106
Net income (loss) (28,954)     (26,156) (2,798)
Ending balance at Jun. 30, 2021 265,594 $ 18 857,948 (619,006) 26,634
Ending balance (in shares) at Jun. 30, 2021   173,686,046,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercised (in shares)   229,889,000      
Exercise of stock options 1,332   1,332    
Exchange of profits interests (in shares)   138,629,000      
Exchange of profits interests 0   1,419   (1,419)
Equity-based compensation 27,906   19,777   8,129
Issuance of common stock in connection with the Business Combination and PIPE Investment (in shares)   71,528,544,000      
Issuance of common stock in connection with the Business Combination and PIPE Investment 656,304 $ 7 656,297    
Transaction costs attributable to the issuance of common stock in connection with the Business Combination and PIPE Investment (70,406)   (70,406)    
Assumption of warrant liability (28,219)   (28,219)    
Change in non-controlling interests allocation 0   21,905   (21,905)
Net income (loss) (59,455)     (58,485) (970)
Ending balance at Sep. 30, 2021 $ 793,056 $ 25 $ 1,460,053 $ (677,491) $ 10,469
Ending balance (in shares) at Sep. 30, 2021 245,583,108 245,583,108,000